Latest from Kromek

Kromek awarded Nuclear Detection contract worth a minimum of $960,000. The Group’s CZT technology to be incorporated into a new radiation detection product available in Asia

The Board of Kromek is pleased to announce that at its General Meeting held today all of the resolutions, as set out in the Circular dated 12 February 2021 relating to a conditional Placing to raise £10.0 million and an Open Offer to raise up to an additional £3.0 million, were duly passed.

The Board of Kromek is pleased to announce that it has received two new orders worth a total of $750,000, with half of this value due to be recognised during the current financial year. The orders are from existing customers in the Group’s medical imaging and nuclear security markets.

Kromek is pleased to announce a conditional Firm Placing, Directors’ Subscription and Open Offer to raise up to £13.0 million before expenses. The Firm Placing has been undertaken with new and existing institutional investors in the Company.

Kromek, alongside Newcastle Upon Tyne Hospitals NHS Foundation Trust (NuTH), are showcasing their early phase research in understanding the problem of dense breasts within breast cancer screening in the UK at the 2021 Symposium Mammographicum conference next week (7th - 10th Feb).

Kromek appeared on BBC Look North last night talking about our new biological threat detection system